AI MARKET SCANNING

IDEAYA Biosciences Inc

📅 Next Catalyst: Nov 09, 2026 (☀️ Open) 🏛️ NASDAQ 📁 Health Technology 🏭 Pharmaceuticals Major
AVG HISTORICAL GAP -0.70%
MAX GAP RECORD -2.78%
🔒 PRO INSTITUTIONAL AI PREDICTIVE WIN RATE
94.2%
REVEAL PRO DIRECTION ⚡

SENTINEL HISTORICAL GAP VIEWER

// $IDYA
📊 1-YEAR TIMELINE (GAPS PLOTTED) 🔮 SIMULATE SETUP 🔒
Bullish Opening Gap Bearish Opening Gap T-1 Close Baseline

CATALYSTS & GAP HISTORY

Nov 09, 2026 Earnings Release 2026-11-09 (BEFORE OPEN (07:00)) 🔮 UPCOMING 🔒
Aug 04, 2026 Earnings Release 2026-08-04 (BEFORE OPEN)
+2.53%
May 05, 2026 Earnings Release 2026-05-05 (BEFORE OPEN)
-2.70%
Feb 17, 2026 Earnings Release 2026-02-17 (BEFORE OPEN)
+0.00%
Nov 04, 2025 Earnings Release 2025-11-04 (BEFORE OPEN)
-1.85%
Aug 05, 2025 Earnings Release 2025-08-05 (BEFORE OPEN)
+0.24%
May 06, 2025 Earnings Release 2025-05-06 (BEFORE OPEN)
+0.10%
Feb 13, 2025 Earnings Release 2025-02-13 (BEFORE OPEN)
-2.78%

VOLATILITY & GAP BIAS

AVG GAP MOVE 1.3%
Bullish Gaps (1)
Bearish Gaps (5)
Neutral / Flat (7)

QUANTITATIVE LIVE RADAR BLOTTER

Algorithmic execution stream for $IDYA

EXECUTIONS1 LOGS
STATUS🔒 ENCRYPTED
Execution Date Strategy & Setup Direction Execution Range Hold Time Net PnL
2026-10-30 🔒 PRO RADAR ••• x• $•••.•• → $•••.•• 3834m +0.15%
🔒 Real-Time Strategy Telemetry Protected

Exact execution levels, Trailing Stops, and live bot signals are reserved for PRO members.

UNLOCK LIVE RADAR ⚡

📖 Intelligence Summary

IDEAYA Biosciences, Inc. engages in the research and development of oncology-focused precision medicine. The firm focuses on the targeted therapeutics for patients selected using molecular diagnostics. Its product candidate, IDE196, is a protein kinase C inhibitor for genetically defined cancers having GNAQ and GNA11 gene mutations. The company was founded…

NEXT UPCOMING PREDICTIVE SIGNAL
STRONG BUY / TARGET +35%
🔓 REVEAL AI SIGNAL & TARGETS ↗